Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 143

1.

[Grading of gynecological tumors : Current aspects].

Horn LC, Mayr D, Brambs CE, Einenkel J, Sändig I, Schierle K.

Pathologe. 2016 Jul;37(4):337-51. doi: 10.1007/s00292-016-0183-7. German.

PMID:
27379622
2.

Detection of Post-Therapeutic Effects in Breast Carcinoma Using Hard X-Ray Index of Refraction Computed Tomography - A Feasibility Study.

Grandl S, Sztrókay-Gaul A, Mittone A, Gasilov S, Brun E, Bravin A, Mayr D, Auweter SD, Hellerhoff K, Reiser M, Coan P.

PLoS One. 2016 Jun 30;11(6):e0158306. doi: 10.1371/journal.pone.0158306. eCollection 2016.

3.

Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.

Stiasny A, Kuhn C, Mayr D, Alexiou C, Janko C, Wiest I, Jeschke U, Kost B.

Anticancer Res. 2016 Jun;36(6):3195-8.

PMID:
27272848
4.

FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.

Freier CP, Kuhn C, Endres S, Mayr D, Friese K, Jeschke U, Anz D.

Anticancer Res. 2016 Jun;36(6):3139-45.

PMID:
27272839
5.

Immunohistochemical Evaluation of the Role of p53 Mutation in Cervical Cancer: Ser-20 p53-Mutant Correlates with Better Prognosis.

Freier CP, Stiasny A, Kuhn C, Mayr D, Alexiou C, Janko C, Wiest I, Jeschke U, Kost B.

Anticancer Res. 2016 Jun;36(6):3131-7.

PMID:
27272838
6.

Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.

Reiter FP, Wimmer R, Wottke L, Artmann R, Nagel JM, Carranza MO, Mayr D, Rust C, Fickert P, Trauner M, Gerbes AL, Hohenester S, Denk GU.

World J Hepatol. 2016 Mar 18;8(8):401-10. doi: 10.4254/wjh.v8.i8.401.

7.

Exclusive enteral nutrition in active pediatric Crohn disease: Effects on intestinal microbiota and immune regulation.

Schwerd T, Frivolt K, Clavel T, Lagkouvardos I, Katona G, Mayr D, Uhlig HH, Haller D, Koletzko S, Bufler P.

J Allergy Clin Immunol. 2016 Mar 14. pii: S0091-6749(16)00202-5. doi: 10.1016/j.jaci.2015.12.1331. [Epub ahead of print] No abstract available.

PMID:
26987574
8.

Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998-2013): a population-based analysis.

Rottmann M, Beck T, Burges A, Dannecker C, Kiechle M, Mayr D, Schlesinger-Raab A, Schubert-Fritschle G, Engel J.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1331-41. doi: 10.1007/s00432-016-2135-2. Epub 2016 Mar 14.

PMID:
26973058
9.

p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer.

Heublein S, Page SK, Mayr D, Ditsch N, Jeschke U.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1163-70. doi: 10.1007/s00432-016-2126-3. Epub 2016 Mar 2.

PMID:
26935926
10.

Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma.

Duewell P, Beller E, Kirchleitner SV, Adunka T, Bourhis H, Siveke J, Mayr D, Kobold S, Endres S, Schnurr M.

Oncoimmunology. 2015 Apr 14;4(10):e1029698. eCollection 2015 Oct.

11.

Fetal gender specific expression of tandem-repeat galectins in placental tissue from normally progressed human pregnancies and intrauterine growth restriction (IUGR).

Hutter S, Knabl J, Andergassen U, Mayr D, Hofmann S, Kuhn C, Mahner S, Arck P, Jeschke U.

Placenta. 2015 Dec;36(12):1352-61. doi: 10.1016/j.placenta.2015.09.015. Epub 2015 Oct 3.

PMID:
26462906
12.

Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.

Anz D, Rapp M, Eiber S, Koelzer VH, Thaler R, Haubner S, Knott M, Nagel S, Golic M, Wiedemann GM, Bauernfeind F, Wurzenberger C, Hornung V, Scholz C, Mayr D, Rothenfusser S, Endres S, Bourquin C.

Cancer Res. 2015 Nov 1;75(21):4483-93. doi: 10.1158/0008-5472.CAN-14-3499. Epub 2015 Oct 2.

PMID:
26432403
13.

Toward Clinically Compatible Phase-Contrast Mammography.

Scherer K, Willer K, Gromann L, Birnbacher L, Braig E, Grandl S, Sztrókay-Gaul A, Herzen J, Mayr D, Hellerhoff K, Pfeiffer F.

PLoS One. 2015 Jun 25;10(6):e0130776. doi: 10.1371/journal.pone.0130776. eCollection 2015.

14.

A survey study on student preferences regarding pathology teaching in Germany: a call for curricular modernization.

Herrmann FE, Lenski M, Steffen J, Kailuweit M, Nikolaus M, Koteeswaran R, Sailer A, Hanszke A, Wintergerst M, Dittmer S, Mayr D, Genzel-Boroviczény O, Eley DS, Fischer MR.

BMC Med Educ. 2015 Jun 2;15:94. doi: 10.1186/s12909-015-0381-7.

15.

Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.

Heublein S, Mayr D, Meindl A, Angele M, Gallwas J, Jeschke U, Ditsch N.

PLoS One. 2015 Jun 1;10(6):e0127072. doi: 10.1371/journal.pone.0127072. eCollection 2015.

16.

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.

Heublein S, Mayr D, Egger M, Karsten U, Goletz S, Angele M, Gallwas J, Jeschke U, Ditsch N.

J Exp Clin Cancer Res. 2015 May 19;34:50. doi: 10.1186/s13046-015-0152-7.

17.

Improved visualization of breast cancer features in multifocal carcinoma using phase-contrast and dark-field mammography: an ex vivo study.

Grandl S, Scherer K, Sztrókay-Gaul A, Birnbacher L, Willer K, Chabior M, Herzen J, Mayr D, Auweter SD, Pfeiffer F, Bamberg F, Hellerhoff K.

Eur Radiol. 2015 Dec;25(12):3659-68. doi: 10.1007/s00330-015-3773-5. Epub 2015 May 9.

18.

Expression of CCL22 and Infiltration by Regulatory T Cells are Increased in the Decidua of Human Miscarriage Placentas.

Freier CP, Kuhn C, Rapp M, Endres S, Mayr D, Friese K, Anz D, Jeschke U.

Am J Reprod Immunol. 2015 Sep;74(3):216-27. doi: 10.1111/aji.12399. Epub 2015 Apr 28.

PMID:
25922986
19.

1,25-(OH)₂-vitamin D₃ prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model.

Reiter FP, Hohenester S, Nagel JM, Wimmer R, Artmann R, Wottke L, Makeschin MC, Mayr D, Rust C, Trauner M, Denk GU.

Biochem Biophys Res Commun. 2015 Apr 3;459(2):227-33. doi: 10.1016/j.bbrc.2015.02.074. Epub 2015 Feb 21.

PMID:
25712522
20.

Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.

Ehrlich SM, Liebl J, Ardelt MA, Lehr T, De Toni EN, Mayr D, Brandl L, Kirchner T, Zahler S, Gerbes AL, Vollmar AM.

J Hepatol. 2015 Jul;63(1):102-13. doi: 10.1016/j.jhep.2015.01.031. Epub 2015 Feb 7.

PMID:
25660209
Items per page

Supplemental Content

Write to the Help Desk